ONCY

Oncolytics Biotech
ONCY

33 hedge funds and large institutions have $1.38M invested in Oncolytics Biotech in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$276K
2
+$60.7K
3
+$20.7K
4
SS
Simplicity Solutions
Minnesota
+$13.9K
5
TRCT
Tower Research Capital (TRC)
New York
+$12.3K

Top Sellers

1
-$42K
2
-$41K
3
-$32.8K
4
Stifel Financial
Stifel Financial
Missouri
-$25.9K
5
Rockefeller Capital Management
Rockefeller Capital Management
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$286K
2
$226K
3
$156K
4
$128K
5
$105K
6
$75K
7
$64K
8
$51.6K
9
$48K
10
$41.6K
11
$40.2K
12
$28K
13
$22.7K
14
$19K
15
$14K
16
$13.9K
17
$11K
18
$9.33K
19
$6.78K
20
$6.36K
21
$6.23K
22
$5.56K
23
$4.81K
24
$4.2K
25
$1.46K
1
2